Docetaxel-carboxymethylcellulose nanoparticles ameliorate CCl4-induced hepatic fibrosis in mice.
Chang CC, Yang Y, Gao DY, Cheng HT, Hoang B, Chao PH, Chen LH, Bteich J, Chiang T, Liu JY, Li SD, Chen Y.
Chang CC, et al. Among authors: yang y.
J Drug Target. 2018 Jun-Jul;26(5-6):516-524. doi: 10.1080/1061186X.2017.1419358. Epub 2017 Dec 27.
J Drug Target. 2018.
PMID: 29251522